NCT05108415View on ClinicalTrials.gov

Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test

UnknownOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
NAFLDNASH - Nonalcoholic Steatohepatitis
Sponsors

Lead Sponsor

HBI Solutions Inc.
All Listed Sponsors
collaborator

mProbe Inc.

INDUSTRY

lead

HBI Solutions Inc.

INDUSTRY

NCT05108415 - Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test | Biotech Hunter | Biotech Hunter